Current and future approaches to antifungal therapy

Current Opinion in Infectious Diseases

Volumn 13, Issue 6, 2000, Pages 579-581

  Patterson, Thomas F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B; FLUCONAZOLE; ITRACONAZOLE; LY 303666; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; ASPERGILLUS; CANDIDA ALBICANS; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; NEPHROTOXICITY; REVIEW;

EID: 0033668358     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200012000-00001     Document Type: Review

References (16)

1. Amphotericin B: 30 Years of clinical experience
2. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
3. Estimating the true cost of amphotericin B
4. Invasive aspergillosis: Disease spectrum, treatment practices, and outcomes
5. Practice guidelines for diseases caused by Aspergillus
6. Practice guidelines for the treatment of candidiasis
7. A randomized trail comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
8. Lipid formulations of amphotericin B: Recent progress and future directions
9. Liposomal amphotericin B for empiric therapy in patients with persistent fever and neutropenia
10. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
11. The efficacy and tolerability of UK109,496 (Voriconazole) in the treatment of invasive aspergillosis
12. The efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis
13. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
14. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis
15. Candiduria: A randomized, double-blind study of treatment with fluconazole placebo
16. Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole